肠道致病性脂聚糖驱动狼疮肾炎系统性血栓炎症
该研究在活检证实的狼疮肾炎(LN)队列中发现,肠道Ruminococcus gnavus(RG)扩增与血小板、中性粒细胞及单核细胞活化相关。抗RG特异性脂聚糖(LG)IgG抗体水平高的患者血小板因子4及中性粒细胞胞外诱捕网(NETs)释放显著升高,验证队列证实抗LG抗体可作为血栓炎症表型的替代标志物。小鼠模型显示产LG的RG定植或单次LG注射引起巨核细胞增多和血小板活化,LG应答依赖Toll样受体2。
要点
- LN患者肠道RG扩增与血小板、中性粒细胞和单核细胞活化相关。
- 抗RG特异性LG抗体可标识LN相关血栓炎症内型。
- 小鼠中产LG的RG定植或LG注射通过TLR2依赖途径诱导血栓炎症和肾小管间质损伤。
核心结论
- 肠道RG致病菌扩增可能通过LG毒素参与自身免疫发病,并通过血栓炎症机制导致该先前未识别的LN内型疾病 flare。
研究设计与样本
- Pilot队列为活检证实的LN患者,按肠道菌群群落分组,采用全血RNA测序文库、血清代表性宿主蛋白水平及抗RG特异性LG的IgG抗体水平进行免疫状态表征。
- 验证LN队列评估血液转录组谱和抗LG抗体水平。
- 小鼠模型在RG肠道定植或腹腔注射LG制剂后,通过转录组分析、血小板功能读数及组织组织学检测机制假设。
主要发现
- Pilot LN队列中,RG肠道扩增与高水平血小板、中性粒细胞和单核细胞活化相关。
- 血清抗新型RG特异性LG的IgG抗体水平高的患者,血小板因子4血清水平和NETs释放显著更高。
- 验证LN队列确认上述关联,并显示抗LG抗体可作为该LN相关内型血栓炎症谱的替代标志物。
- 小鼠中,产LG的RG菌株肠道定植或单次LG注射引起巨核细胞增多和血小板活化;产LG菌株RG定植诱导伴NETosis的肾小管间质损伤。
- 体内对LG毒素的应答依赖Toll样受体2。
临床怎么用
- 抗RG特异性LG抗体可能作为识别LN血栓炎症内型的替代标志物。
- 产LG的RG菌株及LG毒素通过TLR2依赖机制驱动血栓炎症,提示该通路为潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The gut microbiome plays a crucial role in regulating systemic immunity and has been implicated in several chronic inflammatory diseases. Intestinal expansions of Ruminococcus gnavus (RG), a dominant gut commensal, correlate with disease flares in lupus nephritis (LN), but the underlying mechanism remains unknown. METHODS: In a Pilot cohort of patients with biopsy-proven LN, subsetted by gut microbiota community, immune status was characterised using bulk-blood RNA sequencing libraries, serum levels of representative host proteins, and levels of immunoglobulin (Ig)G antibodies to the novel lipoglycan (LG) produced by pathogenic RG strains. A Validation LN cohort was evaluated for blood transcriptomic profiles and levels of anti-LG antibodies. In murine models, mechanistic hypotheses were tested after RG gut colonisation or after intraperitoneal injection with an LG preparation, with outcomes determined by transcriptomic analyses, platelet functional readouts, and tissue histology. RESULTS: In a Pilot cohort of patients with LN, RG gut expansions were associated with high-level platelet, neutrophil, and monocyte activation. Serum levels of platelet factor 4 and release of neutrophil extracellular traps (NETs) were significantly higher in patients with high serum IgG antibody against the novel RG-specific LG, a marker of in vivo immune exposure. An LN Validation cohort confirmed these correlates and showed that anti-LG antibodies serve as a surrogate for thromboinflammatory profile in this LN-associated endotype. In mice, gut colonisation with LG-producing RG strains or a single LG injection caused megakaryocytosis and platelet activation; RG colonisation with LG-producing strains induced tubulointerstitial injury with NETosis. In vivo responses to LG toxin were Toll-like receptor 2-dependent. CONCLUSIONS: Gut expansions of the RG pathobiont may contribute to autoimmune pathogenesis through the LG toxin and cause LN flares through thromboinflammatory mechanisms in this previously unrecognised LN endotype.
引用
- Amarnani A, Rivera CF, Cornwell M, et al. A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis. Ann Rheum Dis. 2026. PMID: 42031645. doi:10.1016/j.ard.2026.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。